Does selenium support thyroid antioxidant defense and hormone metabolism?

Biological mechanisms of selenium in the thyroid

• Translational integration into selenoproteins: Selenium is translationally incorporated as the amino acid selenocysteine into thyroid-specific selenoproteins via a dedicated synthesis pathway. This specialized pathway maintains the thyroid gland's status as having one of the highest concentrations of selenium per gram of tissue in the human body.
• Enzymatic antioxidant protection: During thyroid hormone biosynthesis, follicular cells produce hydrogen peroxide ($\text{H}_2\text{O}_2$) via dual oxidases to iodinate thyroglobulin. To neutralize this high local reactive oxygen species (ROS) load, the thyroid relies on selenium-dependent glutathione peroxidases (GPx) and thioredoxin reductases (TrxR). These enzymes catalyze the reduction of toxic $\text{H}_2\text{O}_2$ and lipid hydroperoxides, preserving the physiological redox environment and protecting thyrocytes from apoptotic cell death.
• Regulation of hormone metabolism: Iodothyronine deiodinases (DIO1, DIO2, and DIO3) are selenoproteins that catalyze the removal of specific iodine atoms, controlling the conversion of thyroxine ($\text{T}_4$) into active triiodothyronine ($\text{T}_3$) or routing them to inactive metabolites. These enzymes are highly sensitive to the local redox environment; when antioxidant defenses fail, oxidative stress impairs deiodinase activity, inhibiting active $\text{T}_3$ conversion and promoting hormone inactivation.

Effects of selenium deficiency

• Vulnerability to oxidative injury: Selenium deficiency impairs the activity of GPx and TrxR, directly reducing $\text{H}_2\text{O}_2$ degradation. This leaves thyrocytes highly vulnerable to self-induced oxidative damage, lipid peroxidation, and cell death. Restoring selenium status in cellular models has been shown to protect thyrocytes against hydrogen peroxide-induced injury and reduce apoptotic markers.
• Vulnerability to autoimmunity: Failing antioxidant defenses allow excess ROS to cause cell damage and apoptosis, releasing intracellular thyroid autoantigens. This cellular injury triggers and accelerates autoimmune pathways. Epidemiological and cohort data demonstrate that low selenium status is associated with an increased risk of autoimmune thyroiditis and higher thyroid peroxidase (TPO) antibody seroconversion. In patients with Hashimoto's thyroiditis, selenium deficiency correlates with elevated anti-TPO and anti-thyroglobulin (Tg) antibody levels, whereas correcting a deficiency via supplementation can significantly lower TPO antibodies and reduce markers of oxidative stress, such as malondialdehyde (MDA).

Bottom line

• Selenium is biochemically indispensable for the thyroid; its deficiency directly compromises GPx and TrxR antioxidant enzymes, leaving the gland vulnerable to self-induced oxidative damage, impaired deiodinase-mediated thyroid hormone metabolism, and autoimmune progression. Correcting low selenium levels helps restore these protective pathways and reduce thyroid autoantibodies.